✦ LIBER ✦

Expression of NFκB in human liver disease

✍ Scribed by A. Licata; G. Malizia; K. Blakolmer; W.A. Rudert; P. Luppi; T. Sakamoto; L. Pagliaro; M. Trucco; A.J. Demetris

Book ID: 119527133
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 163 KB
Volume: 34
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(01)81178-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NF-κB signaling and human disease

✍ Swaroop Aradhya; David L Nelson 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 240 KB

NF-κB signaling, liver disease and hepat

NF-κB signaling, liver disease and hepatoprotective agents

✍ Sun, B; Karin, M 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 452 KB

NFκB, cytokines, TLR 3 and 7 expression

NFκB, cytokines, TLR 3 and 7 expression in human end-stage HCV and alcoholic liver disease

✍ Peter Stärkel; Christine De Saeger; Alastair J. Strain; Isabelle Leclercq; Yves 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 737 KB

NF-κB in cardiovascular disease

✍ W. Keith Jones; Maria Brown; Michael Wilhide; Suiwen He; Xiaoping Ren 📂 Article 📅 2005 🏛 Humana Press Inc 🌐 English ⚖ 876 KB

NF-κB in liver diseases: a target for dr

NF-κB in liver diseases: a target for drug therapy

✍ Pablo Muriel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

## Abstract There are five nuclear factor‐__κ__B (NF‐__κ__B) transcription factors with important roles in innate immunity, liver inflammation, fibrosis and apoptosis prevention. Several inhibitors of NF‐__κ__B, like caffeic acid, captopril, curcumin, pyrrolidine dithiocarbamate, resveratrol, silym

Gossypol suppresses NF-κB activity and N

Gossypol suppresses NF-κB activity and NF-κB-related gene expression in human leukemia U937 cells

✍ Dong-Oh Moon; Mun-Ock Kim; Jae-Dong Lee; Gi-Young Kim 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 282 KB